Literature DB >> 6421735

Isolation and characterization of alkaline protease-deficient mutants of Pseudomonas aeruginosa in vitro and in a mouse eye model.

T R Howe, B H Iglewski.   

Abstract

Mutants of Pseudomonas aeruginosa are described which are markedly deficient in alkaline protease production. Characterization of these mutants in vitro suggests that the mutations in two of these strains are specific for alkaline protease production. Examination of these mutants in a mouse eye model demonstrates that alkaline protease is required for the establishment of corneal infections with P. aeruginosa PA103. Mutants deficient in alkaline protease production could not colonize traumatized cornea and did not produce the corneal damage characteristic of infection by the parental strain. Addition of subdamaging amounts of alkaline protease to eyes infected with the protease-deficient mutants resulted in infections which were indistinguishable from infections caused by the parental strain.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6421735      PMCID: PMC264293          DOI: 10.1128/iai.43.3.1058-1063.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Acetylornithinase of Escherichia coli: partial purification and some properties.

Authors:  H J VOGEL; D M BONNER
Journal:  J Biol Chem       Date:  1956-01       Impact factor: 5.157

3.  Mutants of Escherichia coli requiring methionine or vitamin B12.

Authors:  B D DAVIS; E S MINGIOLI
Journal:  J Bacteriol       Date:  1950-07       Impact factor: 3.490

Review 4.  Cornea and sclera.

Authors:  P R Laibson
Journal:  Arch Ophthalmol       Date:  1972-11

5.  In vitro production of an extracellular protease by Legionella pneumophila.

Authors:  M R Thompson; R D Miller; B H Iglewski
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

6.  Effectiveness of immunization with single and multi-component vaccines prepared from a common antigen (OEP), protease and elastase toxoids of Pseudomonas aeruginosa on protection against hemorrhagic pneumonia in mink due to P. aeruginosa.

Authors:  J Y Homma; C Abe; K Tanamoto; Y Hirao; K Morihara; H Tsuzuki; R Yanagawa; E Honda; Y Aoi; Y Fujimoto; M Goryo; N Imazeki; H Noda; A Goda; S Takeuchi; T Ishihara
Journal:  Jpn J Exp Med       Date:  1978-04

7.  Modulatory effect of iron on the pathogenesis of Pseudomonas aeruginosa mouse corneal infections.

Authors:  D E Woods; P A Sokol; B H Iglewski
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

8.  Purification of Pseudomonas aeruginosa proteases and microscopic characterization of pseudomonal protease-induced rabbit corneal damage.

Authors:  A S Kreger; L D Gray
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

9.  Role of fibronectin in the prevention of adherence of Pseudomonas aeruginosa to buccal cells.

Authors:  D E Woods; D C Straus; W G Johanson; J A Bass
Journal:  J Infect Dis       Date:  1981-06       Impact factor: 5.226

10.  Locus of the Pseudomonas aeruginosa toxin A gene.

Authors:  L F Hanne; T R Howe; B H Iglewski
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.476

View more
  45 in total

Review 1.  Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens.

Authors:  Thomas Bjarnsholt; Michael Givskov
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-07-29       Impact factor: 6.237

2.  Pseudomonas aeruginosa alkaline protease: evidence for secretion genes and study of secretion mechanism.

Authors:  J Guzzo; J M Pages; F Duong; A Lazdunski; M Murgier
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

3.  Proteomic characterization of the whole secretome of Legionella pneumophila and functional analysis of outer membrane vesicles.

Authors:  Frank Galka; Sun Nyunt Wai; Harald Kusch; Susanne Engelmann; Michael Hecker; Bernd Schmeck; Stefan Hippenstiel; Bernt Eric Uhlin; Michael Steinert
Journal:  Infect Immun       Date:  2008-02-04       Impact factor: 3.441

4.  Isolation and characterization of a transposon-induced cytotoxin-deficient mutant of Pseudomonas aeruginosa.

Authors:  L H Bopp; A L Baltch; M C Hammer; M A Franke; R P Smith; F Lutz
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

5.  Genome-Wide Survey of Pseudomonas aeruginosa PA14 Reveals a Role for the Glyoxylate Pathway and Extracellular Proteases in the Utilization of Mucin.

Authors:  Jeffrey M Flynn; Chi Phan; Ryan C Hunter
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

6.  Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes.

Authors:  J P Pearson; E C Pesci; B H Iglewski
Journal:  J Bacteriol       Date:  1997-09       Impact factor: 3.490

7.  Pseudomonas elastase acts as a virulence factor in burned hosts by Hageman factor-dependent activation of the host kinin cascade.

Authors:  I A Holder; A N Neely
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

8.  Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals.

Authors:  J P Pearson; C Van Delden; B H Iglewski
Journal:  J Bacteriol       Date:  1999-02       Impact factor: 3.490

9.  Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S.

Authors:  T I Nicas; B H Iglewski
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

10.  Epigenetic control of virulence gene expression in Pseudomonas aeruginosa by a LysR-type transcription regulator.

Authors:  Keith H Turner; Isabelle Vallet-Gely; Simon L Dove
Journal:  PLoS Genet       Date:  2009-12-18       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.